For Immediate Release
February 22, 2018
Bethesda, Md. – AABB, the leading organization representing the transfusion medicine and cellular therapy communities, announced today that it has appointed Debra BenAvram, FASAE, CAE, as its new Chief Executive Officer (CEO), effective June 1. She will succeed Tom Hopkins, who has served as interim CEO since 2016.
BenAvram brings extensive experience in association management, including a passion for designing strong organizational cultures that drive innovation. Since 2007, she has served as the CEO for the American Society for Parenteral and Enteral Nutrition (ASPEN), an international, interdisciplinary organization dedicated to improving patient care by advancing the science and practice of clinical nutrition and metabolism. Throughout her tenure, BenAvram has partnered with staff, volunteer leaders, corporate partners and other stakeholders to achieve strong strategic and financial growth.
“Debra is a dynamic leader whose proven track record of success, as well as her belief in our mission, make her the perfect choice to take AABB to new heights,” said AABB President Mary Beth Bassett, BS, MT(ASCP). “We’re thrilled to welcome Debra to the AABB family.”
Prior to serving as ASPEN’s CEO, BenAvram served as its Associate Executive Director, overseeing its education, research, certification and publications programs. Before joining ASPEN, she served as the Director of Programs at the American Occupational Therapy Foundation, a sister organization to the American Occupational Therapy Association.
A leader in the association community, BenAvram is a Fellow of the American Society for Association Executives and a Certified Association Executive. She was recognized as a Forty Under 40 Business Leader by the Washington Business Journal in 2015 and a Forty Under 40 Association Leader by Association Forum of Chicagoland and USAE News in 2013. She currently serves on the Board of Directors of the Center for Survivor Agency and Justice and the American Society for Association Executives.
“I am honored and excited to lead AABB and build on its rich history as the leader in the fields of transfusion medicine, cellular therapies and patient blood management,” said BenAvram. “AABB’s commitment to providing the safest and best care possible for donors and patients, and building an environment where its members can succeed and thrive, are second to none. I look forward to collaborating with the staff and members to advance our mission of making transfusion medicine and cellular therapies safe, available and effective worldwide.”
The CEO search was conducted by association and non-profit search experts Vetted Solutions.
AABB is an international, not-for-profit association representing individuals and institutions involved in the fields of transfusion medicine and biotherapies. The association is committed to improving health through the development and delivery of standards, accreditation and educational programs that focus on optimizing patient and donor care and safety. AABB membership includes physicians, nurses, scientists, researchers, administrators, medical technologists and other health care providers. AABB members are located in more than 80 countries and AABB accredits institutions in more than 50 countries.